|Substance group||CAS RN||Common name||DSL name||Public comments on the draft screening assessment||Final screening assessment||Conclusion on section 64 criteria||Follow-up activities|
|Heterocycles Group||100-97-0||Methenamine||1,3,5,7-tetraazatricyclo[18.104.22.168,7]decane||HTML||HTML||Does not meet||None planned at this time|
|June 8, 2019||Publication of the final screening assessment. The related notice was published in the Canada Gazette, Part I: Vol. 153, No. 23.|
|November 11, 2017||Publication and start of 60-day public comment period on the draft screening assessment (including follow-up activities for ETU and CAS RN 4174-09-8). The related notice was published in the Canada Gazette, Part I: Vol. 151, No. 45.|
One additional substance, ETU (CAS RN 96-45-7), was included in the Draft Screening Assessment for the Heterocycles Group. It was subsequently removed from this group and will be assessed at a later date in a separate screening assessment.
Three other substances (CAS RNs 132-65-0, 28984-69-2, and 68909-18-2) were identified as being a part of the Heterocycles Group at the outset of the third phase of the CMP. These substances were subsequently determined to be of low concern to both human health and the environment, through other approaches. Conclusions for these 3 substances are provided in the Screening Assessment for Substances Identified as Being of Low Concern based on the Ecological Risk Classification of Organic Substances and the Threshold of Toxicological Concern (TTC)-based Approach for Certain Substances.
Report a problem or mistake on this page
- Date modified: